-
May 08, 2013
Macro pressures are outweighing solid internal progress at Hologic.
-
January 30, 2013
Qiagen NV (QGEN) reported earnings per share (EPS) of 16 cents in the fourth quarter of 2012, significantly up from ...
-
January 24, 2013
Medtronic Inc. (MDT) has further strengthened its endovascular business. Recently, this leading medical devices ...
-
January 18, 2013
Qiagen NV (QGEN), a key provider of innovative technologies and products for pre-analytical sample preparation and ...
-
January 16, 2013
Cepheid's (CPHD) Xpert CT/NG test has been recently categorized as 'Moderate Complexity' under the Clinical ...
-
January 15, 2013
Recently, Hologic Inc. (HOLX), a prominent player in the women's healthcare market, gained the U.S. Food and Drug ...
-
January 15, 2013
Qiagen (QGEN), a major provider of innovative technologies and products for pre-analytical sample preparation and ...
-
January 10, 2013
In a bid to enhance its Personalized Healthcare diagnostic pipeline, QIAGEN (QGEN) inked three new deals to include ...
-
December 19, 2012
So far today, the Nasdaq is up 0.1%, the S&P 500 has slipped 0.1% and the Dow has remained steady. The healthcare ...
-
November 14, 2012
Hologic (HOLX) reported net loss of $77.8 million or 29 cents per share in the fourth quarter of fiscal 2012 ...
-
November 13, 2012
We reiterate our Neutral recommendation on Thermo Fisher Scientific (TMO) with a target price of $55.00. Thermo ...
-
November 06, 2012
Qiagen (QGEN) reported third quarter 2012 earnings per share (EPS) of 12 cents, compared to 15 cents in the year-ago ...
-
November 05, 2012
Life Tech has the right technology, but 2013 could be a challenging year for the sector.
-
October 17, 2012
Hologic (HOLX), a prominent player in the women's healthcare market, has expanded its diagnostics portfolio. The ...
-
July 31, 2012
Hologic (HOLX) reported net income of $23.6 million or 9 cents per share in the third quarter of fiscal 2012 ...
-
July 25, 2012
Qiagen (QGEN) reported second quarter 2012 earnings of 14 cents per share, in line with the year-ago quarter ...
-
July 20, 2012
Cepheid (CPHD) reported net income of $1.13 million or 2 cents per share in the second quarter of fiscal 2012, lower ...
-
July 19, 2012
Hologic (HOLX), a prominent player in the field of women's health, recently got the Netherlands Society for ...
-
July 09, 2012
Molecular diagnostics solutions provider, Qiagen (QGEN) recently got the nod of the U.S. Food and Drug ...
-
July 09, 2012
Bristol-Myers Squibb Company (BMY) and partner Eli Lilly & Company (LLY) recently announced that they have received ...
